checkAd

     365  0 Kommentare Traders News Source Interviews Evofem Biosciences, Inc. CEO Saundra Pelletier - Seite 3

    Phexxi® is a registered trademark of Evofem Biosciences, Inc.

    Media Contact

    Jack Hirschfield
    Evofem Biosciences, Inc.
    jhirschfield@evofem.com
    (512) 674-5163

    Investor Relations Contact

    Amy Raskopf
    Evofem Biosciences, Inc.
    araskopf@evofem.com
    (917) 673-5775

    About Traders News Source (TNS)

    Traders News Source is a leading independent equity research and corporate access firm focused on finding and reporting on the next hot stocks and market sectors prior to a significant move. TNS is also a financial news provider, focused on giving investors direct access to CEO's of promising, publicly-traded companies, and market experts. Our C-level interviews answer some of the hard hitting questions that rest on the minds of most shareholders. TNS C-level interviews provide valuable insights into the operations and management direction of some of the most promising small and mid-cap publicly traded companies. To review TNS disclosure statement please visit: https://tradersnewssource.com/evofem-interview/

    Media Contact, Traders News Source

    Mark Roberts, Senior Editor/Interviewer Editor@TradersNewsSource.com
    or Call Paul Lipp, President TNS LLC at +1-810-618-1023

    SOURCE: Traders News Source LLC



    View source version on accesswire.com:
    https://www.accesswire.com/704014/Traders-News-Source-Interviews-Evofe ...

    Seite 3 von 3



    Accesswire
    0 Follower
    Autor folgen
    Mehr anzeigen
    We’re a newswire service standout and fast becoming an industry disruptor. We provide regional, national and global news to thousands of clients around the world. We’re also leading the way in social engagement, targeting and analytics.
    Mehr anzeigen

    Verfasst von Accesswire
    Traders News Source Interviews Evofem Biosciences, Inc. CEO Saundra Pelletier - Seite 3 NEW YORK, NY / ACCESSWIRE / June 7, 2022 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid cap publicly traded companies recently issued a new C-Level interview with Evofem Biosciences. …